Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Juliette Cubanski

Medicare's New $50 GLP-1 Weight-Loss Program Just Launched: Find Out if You Qualify

Medicare's GLP-1 Bridge launched July 1, 2026. Up to 3.8M seniors may qualify for $50/month Wegovy, Zepbound, or Foundayo. Here's the eligibility breakdown.

Medical Daily

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans

The Independent UK

Trump’s drug pricing plan gets lukewarm reception

Trump's plan is to establish “most favored nation” pricing to bring U.S. prescription drug pricing more in line with what other countries pay.

Roll Call

From analysis to the latest developments in health,
read the most diverse news in one place.

Prescription drug coverage options are shrinking for Medicare shoppers

Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall

The Independent UK

Future of Medicare drug price negotiations murky under Trump - Roll Call

GOP lawmakers have likened the new drug negotiation law to "government price controls" reducing drug companies' research into new drugs.

Roll Call

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Upcoming changes to the Part D drug benefit, including a $2,000 cap on out-of-pocket medication, will benefit millions of Americans. But higher premiums may also be on the way

Kiplinger

Medicare will negotiate drug prices with Big Pharma for the first time. Here’s how your prescription costs might change

Drug price negotiations will likely be a much bigger deal for the federal government than for many of Medicare’s 65.7 million beneficiaries.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Tensions high as Medicare drug negotiations advance - Roll Call

A law allowing Medicare to negotiate the price of some high-cost drugs remains uncertain, with at least nine lawsuits challenging it.

Roll Call

What are Medicare’s income limits in 2023? Here's how to calculate your costs

The amount you pay for certain types of Medicare premiums varies based on your income.

Fortune

What Medicare beneficiaries need to know about the end of the COVID-19 public health emergency rules

Whether Medicare will or won’t cover certain health care costs may now depend on whether you are in Traditional Medicare or a private insurer’s Medicare Advantage plan.

Fortune

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Senate’s Medicare drug pricing may ripple into private market

Congress is on the verge of passing historic drug pricing legislation that would allow the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift those costs to the private market.

Tribune News Service

Senate's Medicare drug pricing may ripple into private market - Roll Call

Congress is on the verge of allowing the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift costs to the private market.

People

Chiquita BrooksLaSure

14 stories

Juliette Cubanski

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Senate Finance Committee

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.